Global DNA Methylation Market Size Valuation Estimated to Touch USD 3,840.53 Million By 2030, With 14.5% CAGR: Polaris Market Research
January 23, 2023 08:13 ET
|
Polaris Market Research & Consulting LLP
New York, NY, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Polaris Market Research has published a new research report titled “DNA Methylation Market Share, Size, Trends, Industry Analysis Report, By...
Celsion GmbH Announces Commencement of Enrollment in Oxford University’s Phase 1 Study with ThermoDox® and Focused Ultrasound in Pancreatic Cancer
July 01, 2021 08:00 ET
|
Celsion CORP
LAWRENCEVILLE, N.J., July 01, 2021 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), Celsion GmbH, a wholly owned subsidiary of Celsion Corporation, a clinical-stage biotechnology company,...
GynTect soon available in China
April 05, 2017 11:02 ET
|
oncgnostics GmbH
JENA, GERMANY--(Marketwired - Apr 5, 2017) - The Chinese pharma company Changchun Jienuo Medical Technology (CJMT), a subsidiary of the Chinese state-owned SINOPHARM Group (www.sinopharm.com/en),...
MDxHealth annonce ses résultats financiers du 4e trimestre et de l'exercice 2015
February 18, 2016 01:00 ET
|
mdxhealth
Les revenus générés par le test ConfirmMDx sur l'année complète augmentent de 62 % par rapport à 2014 IRVINE, CA, et HERSTAL, BELGIQUE - 7 h 00 - le 18 février 2016 - MDxHealth SA (Euronext:...
MDxHealth Reports Fourth Quarter and Fiscal Year 2015 Results
February 18, 2016 01:00 ET
|
mdxhealth
Full Year ConfirmMDx Revenue up 62% Compared to Full Year 2014 IRVINE, CA, and HERSTAL, BELGIUM - 7:00 AM, February 18, 2016 - MDxHealth SA (Euronext: MDXH.BR) today announced its financial...
Safe Diagnostics for Women Tested HPV-Positive
January 20, 2016 09:00 ET
|
oncgnostics GmbH
JENA, GERMANY and FRICKENHAUSEN, GERMANY--(Marketwired - Jan 20, 2016) - With the start of 2016 the distribution of the cervical cancer triage test GynTect® by Greiner Bio-One has started. For...
Fast and Reliable Results in Cancer Diagnostics: Biotech Startup Oncgnostics Receives CE Mark for Cervical Cancer Test "GynTect"
September 18, 2015 07:00 ET
|
oncgnostics GmbH
JENA, GERMANY--(Marketwired - Sep 18, 2015) - A new test for use in cervical cancer screening is CE-IVD marked in the whole of Europe with immediate effect. It may quickly yield reliable test...
Fast and Reliable Results in Cancer Diagnostics: Biotech Startup Oncgnostics Receives CE Mark for Cervical Cancer Test "GynTect"
September 17, 2015 21:00 ET
|
oncgnostics GmbH
JENA, GERMANY--(Marketwired - Sep 17, 2015) - A new test for use in cervical cancer screening is CE-IVD marked in the whole of Europe with immediate effect. It may quickly yield reliable test...
MDxHealth communique ses résultats du 1er semestre 2015
August 20, 2015 01:00 ET
|
mdxhealth
Le chiffre d'affaires est en hausse de 64 % pour atteindre 7,9 millions de $ Les revenus provenant du test ConfirmMDx augmentent de 77 % pour atteindre 6,9 millions de $ La trésorerie se...
MDxHealth Reports First Half 2015 Results
August 20, 2015 01:00 ET
|
mdxhealth
Revenues up 64% to $7.9 million ConfirmMDx revenue up 77% to $6.9 million Cash position strengthened with $31.0 million private placement enabling greater expansion of sales force and...